Results 141 to 150 of about 209,469 (234)

BRD9 inhibition as potential treatment option for testicular germ cell tumors

Andrology, EarlyView.
Abstract Background Testicular germ cell tumors (TGCT) are the predominant tumor in younger males. Usually, 5‐year survival rates are quite high, but 15–20% of patients with metastatic non‐seminomas are resistant to standard cisplatin‐based therapy.
Aylin Hansen, Christine Sanders, Florian Fronhoffs, Kai Funke, Glen Kristiansen, Hubert Schorle   +5 more
wiley   +1 more source

Váltás a Tér és Társadalom szerkesztőségében

Tér és Társadalom, 2019
Barta Györgyi, Váradi Monika Mária
doaj   +1 more source

Kolozsvár - Mátyás király tér : levelező-lap (157 sz)

, 2015
Kolozsvár - Mátyás király tér [material iconografic] : levelező-lap (157 sz). - Kolozsvár : Kováts P. Fiai, [191-?].

core  

Inhibition of HMGA2 Leads to Reduced Cell Proliferation and Increased Apoptosis in Human Embryonal Carcinoma Cell Lines

Andrology, EarlyView.
ABSTRACT Background The most prevalent solid tumors in young men are testicular germ cell tumors (TGCTs), and embryonal carcinoma is the most common subtype among non‐seminomatous germ cell tumors (NSGCTs). Despite the excellent cure rates of cisplatin‐based chemotherapy, resistance develops in 15%–30% of patients with metastatic cancer, which results ...
Marco De Martino, Matteo Lampitto, Alfredo Fusco, Marco Barchi, Francesco Esposito, Paolo Chieffi   +5 more
wiley   +1 more source

Kisebbségi tér, retardált városfejlődés

Tér és Társadalom, 1996
A. Gergely András
doaj   +1 more source

Influence of Continuous Predictor Modelling Methods on Prediction Stability in Clinical Prediction Model Development: An Empirical Comparison Using Real Clinical Data. [PDF]

Clin Epidemiol
Phinyo P, Wongyikul P, Jirattikanwong N, Isaradech N, Kiratipaisarl W, Lawanaskol S, Seesuwan N, Sirikul W.   +7 more
europepmc   +1 more source

The Functional Role and Molecular Characterization of the Therapeutic Target CLDN6 in Germ Cell Tumors

Andrology, EarlyView.
ABSTRACT Background The tight junction protein CLDN6 has been identified as a cancer‐associated cell surface marker that is rarely expressed in healthy tissues. In testicular germ cell tumors (GCT), CLDN6 is particularly detectable in seminomas, embryonal carcinomas, and choriocarcinomas.
Jule Zwick, Margaretha A. Skowron, Gereon Poschmann, Patrick Petzsch, Ann Kathrin Bergmann, Kai Stühler, Jochen Hecht, Daniel Nettersheim   +7 more
wiley   +1 more source

Dusek Tamás: Tér és közgazdaságtan

Tér és Társadalom, 2014
Lux Gábor
doaj   +1 more source

Running Constraints Shape Multifractal Movement Complexity Beyond Physiological and Mechanical Load: A Pilot Study. [PDF]

Sensors (Basel)
Teixeira A, Abrantes C, Santarém D, Mateus N, Sampaio J.   +4 more
europepmc   +1 more source

A Spotlight on Yolk‐sac Tumors: Molecular Pathology, Current Diagnostics, and Novel Therapeutics

Andrology, EarlyView.
ABSTRACT Background Yolk‐sac tumors are an aggressive subtype of testicular cancer that significantly contribute to disease progression and therapy resistance, especially in adults. While testicular cancer generally has high cure rates with cisplatin‐based treatment, adult yolk‐sac tumors often appear as components of mixed tumors with poor response to
Evangelos Prokakis, Lisa Schneider, Felix Bremmer, Daniel Nettersheim   +3 more
wiley   +1 more source